Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.

IF 1.9 Q3 HEALTH CARE SCIENCES & SERVICES
MDM Policy and Practice Pub Date : 2022-12-08 eCollection Date: 2022-07-01 DOI:10.1177/23814683221142267
Teresa C O Tsui, Maureen E Trudeau, Nicholas Mitsakakis, Murray D Krahn, Aileen M Davis
{"title":"Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.","authors":"Teresa C O Tsui, Maureen E Trudeau, Nicholas Mitsakakis, Murray D Krahn, Aileen M Davis","doi":"10.1177/23814683221142267","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction</b>. Generic preference-based instruments inadequately measure breast cancer (BrC) health-related quality-of-life preferences given advances in therapy. Our overall purpose is to develop the Breast Utility Instrument (BUI), a BrC-specific preference-based instrument. This study describes the selection of the BUI items. <b>Methods.</b> A total of 408 patients from diverse BrC health states completed the EORTC QLQ-C30 and BR45 (breast module). For each of 10 dimensions previously assessed with confirmatory factor analysis, we evaluated data fit to the Rasch model based on global model and item fit, including threshold ordering, item residuals, infit and outfit, differential item functioning (age), and unidimensionality. Misfitting items were removed iteratively, and the model fit was reassessed. From items fitting the Rasch model, we selected 1 item per dimension based on high patient- and clinician-rated item importance, breadth of item thresholds, and clinical relevance. <b>Results.</b> Global model fit was good in 7 and borderline in 3 dimensions. Separation index was acceptable in 4 dimensions. Item selection criteria were maximized for the following items: 1) physical functioning (trouble taking a long walk), 2) emotional functioning (worry), 3) social functioning (interfering with social activities), 4) pain (having pain), 5) fatigue (tired), 6) body image (dissatisfied with your body), 7) systemic therapy side effects (hair loss), 8) sexual functioning (interest in sex), 9) breast symptoms (oversensitive breast), and 10) endocrine therapy symptoms (problems with your joints). <b>Conclusions</b>. We propose 10 items for the BUI. Our next steps include assessing the measurement properties prior to eliciting preference weights of the BUI.</p><p><strong>Highlights: </strong>A previous confirmatory factor analysis established 10 dimensions of the European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30) and its breast module (BR45).In this study, we selected 1 item per dimension based on fit to the Rasch model, patient- and clinician-rated item importance, breadth of item thresholds, and clinical relevance.These items form the core of the future Breast Utility Instrument (BUI).The future BUI will be a novel breast cancer-specific preference-based instrument that potentially will better reflect women's preferences in clinical decision making and cost utility analyses.</p>","PeriodicalId":36567,"journal":{"name":"MDM Policy and Practice","volume":"7 2","pages":"23814683221142267"},"PeriodicalIF":1.9000,"publicationDate":"2022-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/81/10.1177_23814683221142267.PMC9747890.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MDM Policy and Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23814683221142267","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction. Generic preference-based instruments inadequately measure breast cancer (BrC) health-related quality-of-life preferences given advances in therapy. Our overall purpose is to develop the Breast Utility Instrument (BUI), a BrC-specific preference-based instrument. This study describes the selection of the BUI items. Methods. A total of 408 patients from diverse BrC health states completed the EORTC QLQ-C30 and BR45 (breast module). For each of 10 dimensions previously assessed with confirmatory factor analysis, we evaluated data fit to the Rasch model based on global model and item fit, including threshold ordering, item residuals, infit and outfit, differential item functioning (age), and unidimensionality. Misfitting items were removed iteratively, and the model fit was reassessed. From items fitting the Rasch model, we selected 1 item per dimension based on high patient- and clinician-rated item importance, breadth of item thresholds, and clinical relevance. Results. Global model fit was good in 7 and borderline in 3 dimensions. Separation index was acceptable in 4 dimensions. Item selection criteria were maximized for the following items: 1) physical functioning (trouble taking a long walk), 2) emotional functioning (worry), 3) social functioning (interfering with social activities), 4) pain (having pain), 5) fatigue (tired), 6) body image (dissatisfied with your body), 7) systemic therapy side effects (hair loss), 8) sexual functioning (interest in sex), 9) breast symptoms (oversensitive breast), and 10) endocrine therapy symptoms (problems with your joints). Conclusions. We propose 10 items for the BUI. Our next steps include assessing the measurement properties prior to eliciting preference weights of the BUI.

Highlights: A previous confirmatory factor analysis established 10 dimensions of the European Organisation for Research and Treatment of Cancer (EORTC) core quality of life questionnaire (QLQ-C30) and its breast module (BR45).In this study, we selected 1 item per dimension based on fit to the Rasch model, patient- and clinician-rated item importance, breadth of item thresholds, and clinical relevance.These items form the core of the future Breast Utility Instrument (BUI).The future BUI will be a novel breast cancer-specific preference-based instrument that potentially will better reflect women's preferences in clinical decision making and cost utility analyses.

Abstract Image

Abstract Image

Abstract Image

开发 "乳房效用工具 "以测量乳腺癌患者与健康相关的生活质量偏好:为每个维度选择项目。
导言。鉴于治疗方法的进步,基于偏好的通用工具不足以衡量乳腺癌(BrC)患者与健康相关的生活质量偏好。我们的总体目标是开发出乳腺癌特异性偏好工具--乳腺效用工具(BUI)。本研究介绍了 BUI 项目的选择。方法。共有 408 名来自不同乳腺癌健康状况的患者完成了 EORTC QLQ-C30 和 BR45(乳腺模块)。对于之前通过确证因子分析评估的 10 个维度中的每一个维度,我们都根据整体模型和项目拟合度评估了数据与 Rasch 模型的拟合度,包括阈值排序、项目残差、infit 和 outfit、项目功能差异(年龄)以及单维性。反复删除不符合模型的项目,并重新评估模型的拟合度。从符合 Rasch 模型的项目中,我们根据患者和临床医生评价的项目重要性、项目阈值的广度和临床相关性,每个维度选择了 1 个项目。结果7个维度的总体模型拟合度良好,3个维度的拟合度处于边缘状态。4个维度的分离指数可以接受。以下项目的选择标准达到了最大化:1)身体功能(长途跋涉有困难);2)情绪功能(担心);3)社会功能(影响社会活动);4)疼痛(疼痛);5)疲劳(疲倦);6)身体形象(对自己的身体不满意);7)系统治疗副作用(脱发);8)性功能(对性生活感兴趣);9)乳房症状(乳房过于敏感);10)内分泌治疗症状(关节问题)。结论。我们为 BUI 提出了 10 个项目。我们下一步的工作包括在确定 BUI 偏好权重之前评估其测量属性:在本研究中,我们根据 Rasch 模型的拟合度、患者和临床医生评定的项目重要性、项目阈值的广度以及临床相关性,为每个维度选择了 1 个项目。这些项目构成了未来乳腺效用工具(BUI)的核心。未来的乳腺效用工具将是一种基于偏好的新型乳腺癌特异性工具,有可能在临床决策和成本效用分析中更好地反映女性的偏好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MDM Policy and Practice
MDM Policy and Practice Medicine-Health Policy
CiteScore
2.50
自引率
0.00%
发文量
28
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信